REG - Coca-Cola EP PLC - Transactions in Own Shares and Programme Update

Coca-Cola Europacific PartnersAnnouncement

Mon 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250929:nRSc1065Ba&default-theme=true

RNS Number : 1065B  Coca-Cola Europacific Partners plc  29 September 2025

Coca-Cola Europacific Partners plc (the "Company")

Transactions in Own Shares and Programme Update

Repurchase of shares on 26 September 2025

The Company confirms that on 26 September 2025 it purchased a total of: (i)
40,189 ordinary shares of EUR 0.01 ("ordinary shares") on the US Trading
Venues(( 1  (#_ftn1) )) and (ii) 0 ordinary shares on the London Trading
Venues(( 2  (#_ftn2) )); in both cases, from Goldman Sachs & Co. LLC,
Goldman Sachs International or one of their affiliates, as detailed below.

The purchases form part of the third tranche of the Company's share buyback
programme announced on 14 February 2025 (the "Programme"). In connection with
the Programme, the Company expects to repurchase up to EUR 1 billion of
ordinary shares (in aggregate).

All shares repurchased as part of the Programme have been or will be
cancelled.

Programme update

·    Following completion of the first two tranches of the Programme, the
Company announced the third tranche of the Programme on 8 August 2025.

·   The Company today announces that it has concluded the third tranche of
the Programme ahead of schedule (acquiring in total 1,794,369 ordinary shares
for total consideration of approximately €137,921,006.04) and has entered
into a new arrangement for the next tranche of the Programme with Jefferies
LLC and Jefferies International Limited. Share purchases will be made in
accordance with the arrangement and made independently of and uninfluenced by
the Company. The purpose of the Programme is to reduce the issued share
capital of the Company.

·     In connection with the appointment of Jefferies LLC and Jefferies
International Limited, the Company has entered into two contracts to enable
the purchase of ordinary shares on both US Trading Venues and London Trading
Venues. The next tranche of the Programme is expected to cover the period from
29 September 2025 up to and including 19 December 2025.

·   The maximum aggregate amount for purchases in respect of this tranche of
the Programme will be €382,000,000, of which up to €102,000,000 will be in
respect of the London Trading Venues (with purchases on the London Trading
Venues expected to be completed by 12 December 2025).

·    Purchases pursuant to this tranche of the Programme will be effected
in accordance with (i) (in relation to purchases made on the London Trading
Venues) the scope of the authority to repurchase ordinary shares "on market"
conferred on the Company at the 2025 Annual General Meeting (ii) (in relation
to purchases made on the US Trading Venues) the scope of the authority to
repurchase ordinary shares "off market" conferred on the Company at the 2025
Annual General Meeting; (iii) (in relation to purchases made on the London
Trading Venues) (EU) No 596/2014 (the Market Abuse Regulation) and the
Commission Delegated Regulation (EU) 2016/1052 as applicable (both as in force
in the UK, and as they form part of retained UK law as defined in
the European Union (Withdrawal) Act 2018), (iv) Chapter 9 of
the UK Listing Rules; and (v) applicable U.S. federal securities laws,
including applicable US securities laws and anti-manipulation provisions
thereof. In relation to purchases on the London Trading Venues, Jefferies will
acquire CREST depositary interests on the London Trading Venues, which will be
cancelled together with the underlying shares they represent.

·    The maximum number of ordinary shares which may be purchased or
committed to be purchased by the Company under the contracts entered into in
respect of this tranche of the Programme is 46,016,093 less such number of
shares repurchased pursuant to the initial tranche of the Programme after 3
April 2025 and before 22 May 2025 (which is the maximum number pursuant to the
relevant authorities granted by shareholders at the Company's 2025 Annual
General Meeting), less such number of shares repurchased from 23 May 2025 up
to and including 26 September 2025 in relation to prior tranches of the
Programme.

Repurchase of shares on 26 August 2025

                                                          US Trading Venues  London Stock Exchange  CBOE Europe Limited  CBOE Europe Limited

                                                                                                    (CXE)                (BXE)

 Date of purchase                                         26 September 2025  26 September 2025      26 September 2025    26 September 2025
 Aggregate number of ordinary shares purchased            40,189             0                      0                    0
 Highest price paid (per ordinary share)                  USD 89.7700        GBP 0.0000             GBP 0.0000           GBP 0.0000
 Lowest price paid (per ordinary share)                   USD 88.3300        GBP 0.0000             GBP 0.0000           GBP 0.0000
 Volume weighted average price paid (per ordinary share)  USD 89.2170        GBP 0.0000             GBP 0.0000           GBP 0.0000

 

This announcement does not constitute, or form part of, an offer or
solicitation of an offer for securities in any jurisdiction.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it
applies in the UK (the Market Abuse Regulation), full details of the
transactions, are set out in the Schedule to this announcement available
through the link below:

http://www.rns-pdf.londonstockexchange.com/rns/1065B_1-2025-9-28.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/1065B_1-2025-9-28.pdf)

 

CONTACTS

 Company Secretariat     Investor Relations       Media Relations

 Clare Wardle            Sarah Willett            Shanna Wendt

 clare.wardle@ccep.com   sarah.willett@ccep.com   mediaenquiries@ccep.com

 

ABOUT CCEP

Coca-Cola Europacific Partners is one of the world's leading consumer goods
companies. We make, move and sell some of the world's most loved brands -
serving nearly 600 million consumers and helping over 4 million customers
across 31 countries grow.

We combine the strength and scale of a large, multi-national business with an
expert, local knowledge of the customers we serve and communities we support.

The Company is currently listed on Euronext Amsterdam, NASDAQ, London Stock
Exchange and on the Spanish Stock Exchanges, and a constituent of both the
NASDAQ 100 and FTSE 100 indices, trading under the symbol CCEP.

For more information about CCEP, please visit www.cocacolaep.com and follow
CCEP on LinkedIn

Cautionary note on forward-looking statements

This release contains statements, estimates or projections that constitute
"forward-looking statements" concerning the financial condition, performance,
results, guidance and outlook, dividends, consequences of mergers,
acquisitions, joint ventures, divestitures, strategy and objectives
of Coca-Cola Europacific Partners plc and its subsidiaries (together CCEP or
the Group). Generally, the words "ambition", "target", "aim", "believe",
"contemplate", "expect", "intend", "estimate", "anticipate", "project",
"plan", "seek", "may", "could", "would", "should", "might", "will",
"forecast", "outlook", "guidance", "possible", "potential", "predict",
"objective" and similar expressions identify forward-looking statements, which
generally are not historical in nature.

Forward-looking statements are subject to certain risks that could cause
actual results to differ materially. Forward-looking statements are based upon
various assumptions as well as CCEP's historical experience and present
expectations or projections. As a result, undue reliance should not be placed
on forward-looking statements, which speak only as of the date on which they
are made. Factors that, in CCEP's view, could cause such actual results to
differ materially from forward looking statements include, but are not limited
to, those set forth in the "Risk Factors" section of CCEP's 2024 Annual Report
on Form 20-F filed with the SEC on 21 March 2025 and subsequent filings.

 

 

 

 

 1  (#_ftnref1) The "US Trading Venues" comprise Nasdaq and other applicable
US trading venues.

 2  (#_ftnref2) The "London Trading Venues" comprise the London Stock
Exchange, CBOE Europe Limited (BXE), CBOE Europe Limited (CXE) and Aquis.
Goldman Sachs acquired CREST Depositary Interests on the London Trading
Venues, which will be cancelled together with the underlying shares they
represent.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSSEIFMAEISEIU